Eplerenone in mild HF trial stopped early due to drug benefit
Links shared publicly online about this topic.
- 1,135total visits
Eplerenone in mild HF trial stopped early due to drug benefit
Pfizer is to halt recruitment of patients to the EMPHASIS-HF trial testing its selective aldosterone inhibitor eplerenone in mild heart-failure patients because of a significant benefit of the drug.
View full resource at theheart.org
Most Recently Shared on May 28, 2010 at 3:42 pm By:
Pfizer halts eplerenone HF trial early due to drug benefit: Pfizer is to halt recruitment of patients to the EMPHA... http://bit.ly/adkX5w
Advertisement
